Wednesday, November 16, 2011

Investopedia: Meridian Biosciences - Stealth Income Play

Although healthcare has a lot of attributes that would seem to support healthy dividends (protected markets, high margins, excellent cashflow), there's actually only a fairly limited list of quality income names. Once investors have worked past names like Johnson & Johnson (NYSE:JNJ) and Abbott Labs (NYSE:ABT), most investors have to start looking at pharmaceutical names or accept sub-3% yields.

And there's Meridian Biosciences (Nasdaq:VIVO). An established player in easy-to-use and affordable diagnostic tests, Meridian couples pretty decent growth (and growth potential) with a generous dividend payout. Although this stock is not cheap, it may, nevertheless, appeal to those investors looking for a healthy dividend with some growth upside. 

Click here for more:
http://stocks.investopedia.com/stock-analysis/2011/Meridian-Biosciences--Stealth-Income-Play-VIVO-ALR-CPHD-BDX-GPRO-LMNX-ABT1116.aspx

No comments: